|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/567 | (2006.01) |
| A61K 31/567 | (2013.01) | ||
| A61K 31/4745 | (2006.01) | ||
| G01N 33/86 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 31/4745 | (2013.01) | ||
| A61P 7/00 | (2006.01) | ||
| A61P 7/02 | (2018.01) | ||
| A61P 7/02 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| G01N 33/86 | (2006.01) |
| (11) | Number of the document | 3897654 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19898016.1 |
| Date of filing the European patent application | 2019-12-20 | |
| (97) | Date of publication of the European application | 2021-10-27 |
| (45) | Date of publication and mention of the grant of the patent | 2025-01-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2019/067894 |
| Date | 2019-12-20 |
| (87) | Number | WO 2020/132469 |
| Date | 2020-06-25 |
| (30) | Number | Date | Country code |
| 201862784270 P | 2018-12-21 | US |
| (72) |
MORAITIS, Andreas G. , US
|
| (73) |
Corcept Therapeutics Incorporated ,
101 Redwood Shores Parkway, Redwood City, CA 94065,
US
|
| (54) | TREATMENT OF HYPERCOAGULOPATHY IN CUSHING'S SYNDROME BY ADMINISTRATION OF A GLUCOCORTICOID RECEPTOR MODULATOR |
| TREATMENT OF HYPERCOAGULOPATHY IN CUSHING'S SYNDROME BY ADMINISTRATION OF A GLUCOCORTICOID RECEPTOR MODULATOR |